AGŐćČ˹ٷ˝

STOCK TITAN
  1. Home
  2. SEC-Filings
  3. OGI

Organigram Global Inc SEC Filings

OGI NASDAQ

Welcome to our dedicated page for Organigram Global SEC filings (Ticker: OGI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Organigram Holdings Inc’s multi-tiered grow rooms may be spotless, but its SEC disclosures can feel like a jungle of biological-asset valuations and shifting cannabis regulations. Investors hunting for yield forecasts, segment revenue by brands like SHRED or Edison, or a trace of insider selling know that one 10-K can top 300 pages.

Stock Titan clears the path. Our AI reviews every document the minute it hits EDGAR, translating technical notes into plain language and flagging what moves markets. Get Organigram Holdings Inc insider trading Form 4 transactions in real time, compare cultivation costs in the Organigram Holdings Inc quarterly earnings report 10-Q filing, and see risk-factor changes highlighted automatically. Even sudden product-recall updates in an 8-K are summarized before the smoke clears.

  • Organigram Holdings Inc Form 4 insider transactions real-time—custom alerts on executive moves
  • Organigram Holdings Inc annual report 10-K simplified—cash burn, biological asset gains, capital plans
  • Organigram Holdings Inc proxy statement executive compensation distilled into clear tables
  • Organigram Holdings Inc 8-K material events explained with cannabis-sector context
  • Organigram Holdings Inc earnings report filing analysis for brand-level growth trends

Use the platform to monitor executive stock transactions Form 4 before material events, satisfy auditors asking for “Organigram Holdings Inc SEC filings explained simply,� or tackle complex questions like “understanding Organigram Holdings Inc SEC documents with AI.� No more forensic reading—just precise insights delivered the moment you need them.

Filing

[6-K] Organigram Global Inc. Current Report (Foreign Issuer)

Rhea-AI Summary
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Organigram Global (OGI)?

The current stock price of Organigram Global (OGI) is $1.43 as of July 8, 2025.

What is the market cap of Organigram Global (OGI)?

The market cap of Organigram Global (OGI) is approximately 180.7M.

What is Organigram Holdings Inc's core business?

Organigram Holdings Inc is primarily engaged in the indoor cultivation of cannabis for both medical patients and adult recreational consumers. Their operations focus on producing high-quality, organically grown cannabis under strict regulatory standards.

How does Organigram maintain its product quality?

The company employs advanced indoor cultivation techniques and rigorous quality control measures to ensure every product meets safety, potency, and organic integrity standards. This hands-on approach reinforces its commitment to consistently delivering a premium product.

What regulatory frameworks govern Organigram's operations?

Organigram operates in compliance with Canada’s medical marijuana regulations and subsequent frameworks that oversee recreational cannabis. These regulations ensure that the company adheres to industry best practices for quality and safety.

How is the company positioned within the cannabis market?

Organigram is recognized as a seasoned cannabis producer with a legacy in medical marijuana and an expanding portfolio in the recreational sector. Its dual focus on quality and regulatory compliance enables it to maintain a strong niche within a competitive market.

What distinguishes Organigram's cultivation methods?

The company utilizes sophisticated indoor growing techniques that allow for strict control of environmental conditions. This method not only enhances product quality but also ensures uniformity and safety in every cultivation cycle.

How diverse is Organigram's product portfolio?

Organigram has developed a comprehensive portfolio that spans both medical and recreational cannabis markets. The company offers a variety of cannabis brands designed to meet the specific needs of different consumer segments, from artisanal craft products to high-volume recreational options.

What role does organic production play in Organigram's business?

Organic production is a cornerstone of Organigram’s cultivation strategy, ensuring that the cannabis is grown without harmful chemicals and with a focus on natural growing methods. This approach not only supports product purity but also reinforces consumer trust in the quality of their medicine and recreational products.

How does Organigram differentiate itself from competitors?

Organigram differentiates itself through its long-standing history as a licensed producer and its innovative, state-of-the-art indoor cultivation practices. Its diversified brand portfolio and commitment to regulatory compliance further cement its position as a knowledgeable and reliable company in the cannabis industry.
Stock OGI logo
Organigram Global Inc

NASDAQ:OGI

OGI Rankings

#6116 Ranked by Market Cap
N/A Ranked by Dividends

OGI Stock Data

180.74M
90.39M
34.41%
6.48%
4.28%
Drug Manufacturers - Specialty & Generic
Healthcare
Canada
Toronto